Yellow Fever Immune Response at Single Cell Resolution

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

August 22, 2016

Primary Completion Date

September 5, 2018

Study Completion Date

September 5, 2018

Conditions
Healthy
Interventions
DRUG

Yellow Fever Vaccine

Yellow Fever Vaccine .5 ml

Trial Locations (1)

10065

The Rockefeller University, New York

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Rockefeller University

OTHER

NCT03458780 - Yellow Fever Immune Response at Single Cell Resolution | Biotech Hunter | Biotech Hunter